行业动态
全球精选 ·
@Julie Bort
Anthropic 运营一个开展生物学实验的实验室
TechCrunch 报道称,Anthropic 正在运营一个进行生物学实验的实验室。输入摘要同时提到 AI 领导者对 AI 治愈人类疾病的承诺,以及 Anthropic 研究人员对 AI 风险的警告,但未提供实验细节、规模或可验证证据。
AI推荐理由 TechCrunch 报道 Anthropic 运营一个开展生物学实验的实验室,属于 AI 公司向生物实验领域延伸的具体动向;但输入仅提供摘要,未给出实验内容、规模、合作方或可验证证据,且摘要中关于 AI 治愈疾病与 AI 风险的表述为背景性概括,无法据此判断实际进展,故兴趣分中等、质量分受信息密度限制。
62
正文
Anthropic has confirmed that it has a wet biology lab where it can use its AI models to run physical experiments.
AI leaders have been promising that AI is the key to curing human disease. Dario Amodei opined just last week: “I believe that AI could cure most major diseases in the next 5–10 years.” To do that, an LLM would have to have methods to test its theories in real life.
“We believe that to do biology, the final test is still, and will be for a while, in real lab work,” Anthropic’s head of life sciences, Eric Kauderer-Abrams told Reuters. “We absolutely are doing that today.” He added that the lab operates like most biotech labs: Anthropic conducts some research there while also working with externals partners.
This news probably shouldn’t be shocking. Anthropic bought Coefficient Bio, a stealth AI biotech, in April. It declined to say what the wet lab is working on, except that it’s not focused on drug discovery. Anthropic doesn’t want to give the appearance of competing with the pharma industry, where it has numerous major customers and partners. (For instance, it just announced a deal to work with Novo Nordisk on joint drug discovery.) Anthropic has already faced backlash for launching products perceived to compete with those of its customers.
To that end, Anthropic also launched a Life Sciences Verification Program this week, to give vetted bio researchers access to its most powerful models.
But the world is still reeling from the resignation of Anthropic researcher Jacob Coxon, who warned that “the people building AI earnestly believe that it could kill us all by the end of the decade.” Anthropic’s own alignment lead gave the odds at greater than 10% that AI could exterminate humanity within the next decade.
The fervor has grown so intense that CEO Dario Amodei published a post last weekend calling on the industry to slow down and institute self-regulation. He has repeatedly called bioterrorism one of AI’s biggest risks.
The juxtaposition of these dire warnings and the wet lab has not gone unnoticed in the tech industry. As investor and AI coding startup founder Chamath Palihapitiya posted on X, somewhat tongue-in-cheek: “The group behind such hits as: “We’re All Going To Die” and “Regulate Me Now” are building a wet lab in SF. I do not recommend this.”
Topics
AI, Anthropic, Biotech & Health, TC
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.
Julie Bort
Venture Editor
Julie Bort is the Startups/Venture Desk editor for TechCrunch.
You can contact or verify outreach from Julie by emailing julie.bort@techcrunch.com or via @Julie188 on X.
View Bio